![]() |
市場調查報告書
商品編碼
1988981
焦慮和行為支持產品市場預測至2034年-按產品類型、成分類型、劑型、應用、最終用戶和地區分類的全球分析Anxiety & Behaviour Support Products Market Forecasts to 2034 - Global Analysis By Product Type, By Ingredient Type, By Form, By Application, By End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球焦慮和行為支持產品市場規模將達到 21 億美元,並在預測期內以 9.8% 的複合年成長率成長,到 2034 年將達到 45 億美元。
焦慮和行為支持產品是旨在減輕寵物壓力、攻擊性或恐懼相關行為的介入措施。這些產品包括鎮靜零食、費洛蒙擴散器、穿戴式裝置、行為訓練輔助工具和互動玩具。它們有助於維護寵物心理健康,改善飼主與寵物之間的關係,並提升寵物的生活品質。人們對寵物情緒健康的日益關注、城市化進程的加速以及因分離和環境變化而引發的行為問題,都在推動市場成長。天然成分的運用、智慧監測以及獸醫指導的結合,提高了這些支援產品的有效性、安全性和普及性。
人們越來越關注寵物心理健康
寵物飼主越來越關注寵物的壓力、分離焦慮和行為問題。隨著寵物越來越“擬人化”,它們的心理健康與身體健康同等重要。社群媒體和獸醫宣傳活動提高了人們對放鬆療法的認知。主人願意投資購買有助於改善寵物行為平衡的營養補充品、零食和設備。這種對心理健康日益成長的關注持續推動著全球市場的擴張。
缺乏關於有效性的臨床證據
許多鎮靜零食和補充劑缺乏標準化的測試來證明其療效的穩定性。獸醫和寵物飼主的懷疑態度阻礙了它們在某些地區的普及。監管機構要求在核准新配方之前提供更有力的證據。消費者需求與科學檢驗之間的這種差距造成了市場的不確定性。因此,缺乏臨床支持仍然是阻礙其更廣泛接受度的因素。
人工智慧驅動的行為監測設備
智慧項圈和穿戴式追蹤器能夠監測心率和活動量等壓力指標。人工智慧演算法可提供個人化的鎮靜方案和營養補充建議。透過與行動應用程式整合,飼主可以即時追蹤寵物的行為模式。獸醫診所可以利用這些資訊來制定個人化的治療方案。這項技術創新可望加速高級產品的普及,並提升市場信譽。
對膳食補充劑的監管限制
地方政府對寵物保健品製定了嚴格的指導方針,限制了產品的上市。各國不同的核准流程也阻礙了全球擴張。企業為了達到合規標準,必須承擔延誤和額外成本。虛假宣傳和誇大廣告可能導致產品召回,損害品牌聲譽。這些複雜的監管問題持續阻礙著該行業的成長。
新冠疫情對焦慮和行為支持產品市場產生了複雜的影響。一方面,供應鏈中斷影響了鎮靜補充劑和設備的生產和分銷。另一方面,疫情封鎖期間寵物飼養量的增加推高了對行為支持解決方案的需求。由於居家時間增多,飼主更重視寵物的心理需求。實體店受到限制,線上銷售管道迅速發展。整體而言,疫情加速了數位化進程,同時也凸顯了供應鏈的脆弱性。
在預測期內,鎮靜零食細分市場預計將佔據最大的市場佔有率。
由於其便利性、易獲取性和易於服用,預計在預測期內,鎮靜零食將佔據最大的市場佔有率。寵物飼主更傾向於選擇零食而非營養補充劑,因為偏好且具有功能性優勢。製造商正在開發使用洋甘菊、纈草根和麻提取物等天然成分的產品。鎮靜零食的零售市場滲透率高於其他行為支持產品。人們對寵物壓力管理意識的不斷提高,進一步推動了該細分市場的需求。
在預測期內,獸醫院細分市場預計將呈現最高的複合年成長率。
在預測期內,由於人們越來越依賴專家指導來解決行為問題,獸醫院領域預計將呈現最高的成長率。獸醫院正在將鎮靜劑補充劑和監測設備納入治療方案。獸醫進行的宣傳宣傳活動不斷提高消費者對這些產品的信心。獸醫院也發揮分銷中心的作用,提高了產品的知名度和信譽。獸醫專業人員的個人化建議正在推動高級產品的普及。
在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於其較高的寵物擁有率和強大的購買力。美國和加拿大的消費者對行為支持產品的接受度非常高。知名品牌和獸醫網路正在推動鎮靜零食和營養補充品的普及。與其他地區相比,北美高級產品的零售滲透率更高。強而有力的品牌宣傳活動和數位行銷正在助力市場進一步成長。這些因素共同作用,將確保北美在市場佔有率方面保持領先地位。
在預測期內,受寵物心理健康意識不斷提高和相關法規結構的支持,歐洲地區預計將呈現最高的複合年成長率。德國、法國和英國等國家對行為支持解決方案的需求正在增加。歐洲消費者對天然環保的鎮靜產品表現出極高的興趣。獸醫的推薦和臨床試驗正在提升產品在該地區的信譽度。本土Start-Ups正攜創新的人工智慧監測設備進軍市場。
According to Stratistics MRC, the Global Anxiety & Behaviour Support Products Market is accounted for $2.1 billion in 2026 and is expected to reach $4.5 billion by 2034 growing at a CAGR of 9.8% during the forecast period. Anxiety & Behaviour Support Products are interventions for pets designed to reduce stress, aggression, or fear-related behaviors. They include calming treats, pheromone diffusers, wearable devices, behavioral training aids, and interactive toys. These products support mental health, improve owner-pet relationships, and enhance quality of life. Increasing awareness of pets' emotional wellbeing, the rise of urban living, and behavioral issues due to separation or environmental changes drive market growth. Integration of natural ingredients, smart monitoring, and veterinary guidance enhances efficacy, safety, and adoption of these support products.
Increasing awareness of pet mental health
Pet owners are increasingly recognizing stress, separation anxiety, and behavioural issues in their pets. Rising humanization of pets has led to greater emphasis on emotional well-being alongside physical health. Social media and veterinary campaigns are amplifying awareness about calming solutions. Owners are more willing to invest in supplements, treats, and devices that improve behavioural balance. This heightened focus on mental health continues to fuel market expansion globally.
Limited clinical evidence for efficacy
Many calming treats and supplements lack standardized trials to prove consistent results. Skepticism among veterinarians and pet owners slows adoption in certain regions. Regulatory bodies demand stronger evidence before approving new formulations. This gap between consumer demand and scientific validation creates uncertainty in the market. As a result, limited clinical backing continues to hinder broader acceptance.
AI-based behavioral monitoring devices
Smart collars and wearable trackers can monitor stress indicators such as heart rate and activity levels. AI algorithms provide personalized recommendations for calming routines and supplements. Integration with mobile apps allows owners to track behavioural patterns in real time. Veterinary clinics can use these insights to design tailored treatment plans. This technological innovation is expected to accelerate premium adoption and strengthen market credibility.
Regulatory restrictions on supplements
Authorities in different regions impose strict guidelines on pet supplements, limiting product launches. Variations in approval processes across countries create barriers for global expansion. Companies face delays and added costs in meeting compliance standards. Mislabeling or exaggerated claims can lead to product recalls, damaging brand reputation. This regulatory complexity continues to challenge the industry's growth trajectory.
The Covid-19 pandemic had mixed effects on the anxiety and behaviour support products market. On one hand, supply chain disruptions affected production and distribution of calming supplements and devices. On the other hand, increased pet adoption during lockdowns boosted demand for behavioural support solutions. Owners spending more time at home became more attentive to their pets' emotional needs. Online sales channels grew rapidly as physical retail faced restrictions. Overall, the pandemic accelerated digital adoption while highlighting supply chain vulnerabilities.
The calming treats segment is expected to be the largest during the forecast period
The calming treats segment is expected to account for the largest market share during the forecast period as they are convenient, widely available, and easy to administer. Pet owners prefer treats over supplements due to their palatability and functional benefits. Manufacturers are innovating with natural ingredients such as chamomile, valerian root, and hemp extracts. Retail penetration of calming treats is higher compared to other behavioural support products. Rising awareness of stress management in pets further strengthens demand for this segment.
The veterinary clinics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the veterinary clinics segment is predicted to witness the highest growth rate due to increasing reliance on professional guidance for behavioural issues. Clinics are integrating calming supplements and monitoring devices into treatment plans. Rising awareness campaigns by veterinarians are boosting consumer trust in these products. Clinics also serve as distribution hubs, enhancing product visibility and credibility. Personalized recommendations from veterinary professionals encourage premium adoption.
During the forecast period, the North America region is expected to hold the largest market share owing to high pet ownership rates and strong purchasing power. Consumers in the U.S. and Canada are highly receptive to behavioural support products. Established brands and veterinary networks are driving adoption of calming treats and supplements. Retail penetration of premium products is higher in North America compared to other regions. Strong awareness campaigns and digital marketing further support growth. These factors collectively ensure North America's dominance in market share.
Over the forecast period, the Europe region is anticipated to exhibit the highest CAGR driven by rising awareness of pet mental health and supportive regulatory frameworks. Countries such as Germany, France, and the UK are witnessing increased demand for behavioural support solutions. European consumers are highly receptive to natural and eco-friendly calming products. Veterinary endorsements and clinical trials are strengthening credibility in the region. Local startups are entering the market with innovative AI-based monitoring devices.
Key players in the market
Some of the key players in Anxiety & Behaviour Support Products Market include Nestle Purina PetCare, Mars Petcare, Ceva Sante Animale, Zylkene (Vetoquinol), ThunderShirt, Adaptil (Ceva), Pet Naturals of Vermont, VetriScience Laboratories, Rescue Remedy Pets, HempMy Pet, Honest Paws, Bach Flower Remedies, PetHonesty, NaturVet and Only Natural Pet.
In November 2025, Purina Pro Plan Veterinary announced a partnership with Ease, an online platform for veterinary behaviour specialty care. This collaboration gives veterinary clinics free access to board-certified behaviourists, expanding Purina's support mission to address pet anxiety and behavioural challenges through professional guidance.
In November 2025, Ceva unveiled its Douxo Spa product line for pets during the holiday season. While primarily a dermatology and wellness product, it complements Ceva's behavioural support portfolio by addressing comfort and wellbeing, which are closely linked to stress reduction in pets.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.